The KDIGO
Membership Organizations · New York, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
30 E 33rd St Ste 900, New York City, New...Phone Number
(212) 889-2210Website
www.kdigo.orgRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About The KDIGO
KDIGO is a global nonprofit organization dedicated to improving the care and outcomes of patients with kidney disease through the development and implementation of evidence-based clinical practice guidelines. Their guidelines translate scientific evidence into practical recommendations for clinicians and patients, covering various aspects of kidney disease management. KDIGO serves healthcare professionals and patients worldwide, aiming to enhance kidney health and treatment practices. The organization also hosts conferences and events to foster collaboration and education in the field of nephrology.Explore more
The KDIGO Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is The KDIGO your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on The KDIGO recently announced quarterly report
The KDIGO, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if The KDIGO is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at The KDIGO
Click to see if The KDIGO had a recent Job posting/layoffs
Product Launch: Get notified when The KDIGO launches new products
Funding: Get notified immidiatlly once The KDIGO has new funding data
Check if The KDIGO has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Recommended Actions
Reach out to Masked Content who joined The KDIGO as Masked Content
Find more new buyers
Compare Similar Companies to The KDIGO
Compare insights from companies similar to The KDIGO, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
The KDIGO is experiencing very low activity levels compared to other companies in the Organizations sector.
What does this means?
The KDIGO is drawing exceptional interest within the Organizations industry, suggesting notable developments or strong market momentum, learn more about The KDIGO.
The KDIGO Tech Stack
A closer look at the technologies used by The KDIGO
The KDIGO News & Media
Medscape Education and KDIGO Nephrology Collaboration Accelerates Improvements to Patient Care
LONDON--(BUSINESS WIRE)--Ahead of the 61st European Renal Association (ERA) Congress, Medscape Education and KDIGO (Kidney Disease: Improving Global Outcomes) announce an educational collaboration through a series of webinars to improve anemia-related outcomes in patients with Chronic Kidney Disease on dialysis. Activities will be hosted on www.medscape.org/nephrology and available for AMA credit, starting Summer 2024. The collaboration combines Medscape's 29 years of experience in nephrology,Revolutionizing Chronic Kidney Disease Management on World Kidney Day
LifeLabs Klinrisk Score Included in KDIGO 2024 CKD Guideline LifeLabs Klinrisk Score Included in KDIGO 2024 CKD GuidelineNew KDIGO Guideline Supports Genetic Testing for the Majority of CKD Patients to Establish Cause of Disease
AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, commented today on the 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease, which was recently published by the Kidney Disease Improving Global Outcomes (KDIGO) organization, a leading medical society in nephrology. The updated guideline includes consensus statements supporting the use of genetic testing to establish the cause of chronic kidney diseaseBayer’s KERENDIA® (finerenone) Recommended as Part of Comprehensive Treatment Strategy for Chronic Kidney Disease Associated With Type 2 Diabetes in Newly Published Clinical Recommendations
WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer’s KERENDIA® (finerenone), a first-in-class, non-steroidal mineralocorticoid receptor antagonist (ns-MRA), was recommended as part of a comprehensive treatment strategy for patients with chronic kidney disease (CKD) associated with type 2 diabetes (T2D) in a newly published update to the Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease and in a consensus report jointly issued by
Read more news
Top Membership Organizations Companies
See more top companies
Frequently Asked Questions Regarding The KDIGO
Sign Up For FreeTo access detailed company insights
KDIGO is a global nonprofit organization dedicated to improving the care and outcomes of patients with kidney disease through the development and implementation of evidence-based clinical practice guidelines. Their guidelines translate scientific evidence into practical recommendations for clinicians and patients, covering various aspects of kidney... Read More
